Sign in
LBRX Stock Price, Chart, Stats & News
LB Pharmaceuticals Inc Common Stock
Save
860.30M
Market cap
–
Current P/E
–
Forward P/E
LBRX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.00% |
ROA | -8.05% |
ROE | -19.46% |
D/E | 0.01x |
Interest coverage ratio | – |
LBRX valuation
P/E | – |
P/S | – |
P/B | 2.00x |
P/CF | -17.13x |
P/FCF | -17.11x |
P/OCF | -17.13x |
PEG | -54.76x |
EV multiple | -30.68x |
About
This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression.
Similar securities
Based on sector and market capitalization
Report issue